Literature DB >> 17905823

Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.

M Albers1, T Schermer, Y Heijdra, J Molema, R Akkermans, C van Weel.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is an insidiously starting disease. Early detection has high priority because of the possibility of early implementation of smoking cessation interventions. An evidence based model for case finding of COPD is not yet available.
OBJECTIVE: To describe the early development of COPD, and to assess the predictive value of early signs (respiratory symptoms, lung function below the normal range, reversibility). DESIGN AND METHODS: In a prospective study, based in general practice, formerly undiagnosed subjects (n = 464) were assessed at baseline and at 5 years for respiratory symptoms and pulmonary function. Odds ratios for early signs were calculated (adjusted for age, gender, pack-years at baseline and smoking behaviour during follow-up), and defined as possible indicators of disease progression.
RESULTS: Over a 5 year period, the percentage of subjects with obstruction increased from 7.5% (n = 35) at baseline to 24.8% (n = 115) at 5 years. The presence of mild early signs and lung function below the normal range at baseline were related to an increased risk of developing mild to moderate COPD (GOLD I: OR 1.87 (95% CI 1.22 to 2.87); GOLD II: OR 2.08 (95% CI 1.29 to 3.37) to 2.54 (95% CI 1.25 to 5.19)) at 5 years.
CONCLUSION: Lung function below the normal range and early respiratory signs predict the development and progression of COPD.

Entities:  

Mesh:

Year:  2007        PMID: 17905823     DOI: 10.1136/thx.2006.068007

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

1.  Lung function decrement with arsenic exposure to drinking groundwater along River Indus: a comparative cross-sectional study.

Authors:  Asaad Ahmed Nafees; Ambreen Kazi; Zafar Fatmi; Muhammad Irfan; Arif Ali; Fujio Kayama
Journal:  Environ Geochem Health       Date:  2010-07-15       Impact factor: 4.609

2.  Exposure to PM10 as a risk factor for the development of nasal obstruction and chronic obstructive pulmonary disease.

Authors:  Lazaros Sichletidis; Dionisios Spyratos; Anastasios Tsiotsios; Anna-Bettina Haidich; Ioannis Ganidis; Dimitrios Michailidis; Georgios Triantafyllou; George Kottakis; Dimitrios Melas
Journal:  Int J Occup Environ Health       Date:  2014 Jan-Mar

3.  Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.

Authors:  Reinier P Akkermans; Marvin A Berrevoets; Ivo J Smeele; Annelies E Lucas; Bart P Thoonen; Joke G Grootens-Stekelenburg; Yvonne F Heijdra; Chris van Weel; Tjard R Schermer
Journal:  BMC Pulm Med       Date:  2012-03-22       Impact factor: 3.317

Review 4.  Systematic review of the evidence relating FEV1 decline to giving up smoking.

Authors:  Peter N Lee; John S Fry
Journal:  BMC Med       Date:  2010-12-14       Impact factor: 8.775

5.  Presentation of respiratory symptoms prior to diagnosis in general practice: a case-control study examining free text and morbidity codes.

Authors:  Richard A Hayward; Ying Chen; Peter Croft; Kelvin P Jordan
Journal:  BMJ Open       Date:  2015-06-12       Impact factor: 2.692

6.  Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma: a long-term prospective cohort study.

Authors:  Nicolás Bermúdez Barón; Anne Lindberg; Caroline Stridsman; Martin Andersson; Linnea Hedman; Sigrid Anna Vikjord; Hannu Kankaanranta; Bo Lundbäck; Eva Rönmark; Helena Backman
Journal:  BMJ Open Respir Res       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.